OXYGENTA PHARMACEUTICAL
Back to Cashflow Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹43 Cr | ₹8.49 Cr | ₹17 Cr | ₹11 Cr | ₹6.33 Cr |
What is the latest Cash Flow from Financing Activities ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹43 Cr |
| Mar2025 | ₹8.49 Cr |
| Mar2024 | ₹17 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹6.33 Cr |
How is Cash Flow from Financing Activities of OXYGENTA PHARMACEUTICAL Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹43 Cr | 401.38 | |
| Mar2025 | ₹8.49 Cr | -50.46 | |
| Mar2024 | ₹17 Cr | 52.64 | |
| Mar2023 | ₹11 Cr | 77.26 | |
| Mar2022 | ₹6.33 Cr | - | |
Compare Cash Flow from Financing Activities of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹185.2 Cr | -3.9% | 5.2% | -55.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,993.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -3.9% |
5.2% |
-55.4% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses